University of Utah Biochemist Formulates Anti-HIV Drug, FDA Approves
A research team, led by Wesley Sundquist, Professor and Chair of the University of Utah Biochemistry Department, has developed a drug for HIV (Human Immunodeficiency Virus) prevention. Clinical trials have shown that the drug lenacapavir reduces the sexual transmission of HIV with two injections a year. The Food and Drug Administration FDA) has approved the